1 February 2008   
 

CLSI 2008 Leadership Conference
2 – 4 April 2008
Renaissance Harborplace Hotel
Baltimore, Maryland USA

News
Executive Vice President's Message
Volunteer Focus
CLSI Announces Keynote Address as Part of Upcoming To Your Good Health Workshop
New Website and New Catalog Supplement
Lab Guidelines & Standards
The Evolution of POC Connectivity
New 2008 Teleconference Series
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Events
Upcoming Events
Upcoming Presentations
CLSI Meeting Calendar
Participate in CLSI
Volunteer
Career Opportunities
New and Sustaining Members
Update Your Subscription
 
CLSI Home Page
Search Past Issues
Update Your Contact Information
Print this article Print all articles
 
 
 
 
Recently Approved Documents

User Protocol for Evaluation of Qualitative Test Performance (EP12-A2)
Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays (H21-A5)
Protocol for the Evaluation, Validation, and Implementation of Coagulometers; Approved Guideline (H57-A)
Antimicrobial Susceptibility Testing Standard (M100-S18)


EP12-A2User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline—Second Edition
This document provides a consistent approach for protocol design and data analysis when evaluating qualitative diagnostic tests. Guidance is provided for both precision and method-comparison studies.
Purchase here.

H21-A5Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline—Fifth Edition
This guideline contains procedures for collecting, transporting, and storing blood; processing blood specimens; storing plasma for coagulation testing; and general recommendations for performing the tests.
Purchase here.

H57-AProtocol for the Evaluation, Validation, and Implementation of Coagulometers; Approved Guideline
This document provides guidance and procedures to the end user and manufacturer for the selection, evaluation, validation, and implementation of a laboratory coagulometer.
Purchase here.

Second Notice

M100-S18Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement
The latest recommendations for detecting emerging resistance—arranged in tabular form. Includes updated tables from CLSI’s newest disk (M02-A9) susceptibility and MIC (M07-A7) testing standards.
Purchase here.


Our procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community that participates in the consensus process by carefully reviewing and commenting on the standard or guideline.

 

You may automatically receive or select approved-level documents as a member benefit.  Find out more about joining CLSI:  view membership options and benefits. [ return to top ]

For more information or to contact us directly, please visit www.clsi.org
©2007 Clinical and Laboratory Standards Institute